Many rodent renal and bladder carcinogens rely upon epigenetic mechanisms of carcinogenesis; such mechanisms are likely to influence the spectrum of urinary tract tumors observed in control and treated animals. This is reflected in several features of chemically induced rodent urinary tract neoplasms, including a low overall tumor incidence, an increased prevalence of urinary tract tumors in rats compared to mice and males compared to females, the tendency for epithelial tumors to predominate over nonepithelial types, and demonstrated links to chronic progressive nephropathy and urolithiasis. Such tendencies are also characteristic of spontaneous urinary tract tumors in rodents. Data to support these observations can be derived from large historical databases such as the Toxicology Data Management System, maintained by National Toxicology Program.
Reis LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Edwards BK (eds). (2000). SEER Cancer Statistics Review, 1973—1997. National Cancer Institute, Bethesda, MD.
2.
Boring CC, Squires TS, Tong T. ( 1994). Cancer Statistics 1994. CA Cancer J Clin44: 7—26.
3.
Kassabian VS, Graham SD (1995). Urologic and male genital cancers. In: American Cancer Society Textbook of Clinical Oncology, Murphy GP, Lawrence W , Lenhard RE Jr (eds). American Cancer Society, Atlanta, GA.
4.
International Agency for Research on Cancer (1987). Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs, Vols 1 to 42. IARC Monogr Eval Carcinog Risks (suppl) 7: 310—312.
5.
Wilbourne JD , Partensky C., Rice JM ( 1999). Appendix 1: Agents that induce epithelial neoplasms of the urinary bladder, renal cortex and thyroid follicular lining in experimental animals and humans: Summary of data from IARC Monographs volumes 1—69 . In: Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis, Capen CC, Dybing E, Rice JM, Wilbourne JD (eds). IARC Scientific Publications, No 147, International Agency for Research on Cancer, Lyon, France, pp 191—209.
6.
Haseman JK (1995). Data analysis: Statistical analysis and use of historical control data. Regul Toxicol Pharmacol21: 52—59.
7.
Haseman JK (1992). Value of historical controls in the interpretation of rodent neoplasm data. Drug Inf26: 191—200.
8.
Haseman JK, Huff JE, Boorman GA (1984). Use of historical control data in carcinogenicity studies in rodents. Toxicol Pathol12: 126— 135.
9.
Rao GN, Boorman GA (1999). History of the B6C3F1 mouse. In: Pathology of the Mouse, Maronpot RR, Boorman GA, Gaul BW (eds). Cache River Press, Vienna, IL, pp 1—11.
10.
Rao GN, Boorman GA (1990). History of the Fischer 344 rat. In: Pathology of the Fischer Rat: Reference and Atlas, Boorman GA, Eustis SL, Elwell MR, Montgomery CA Jr, MacKenzie WF (eds). Academic Press, Inc, San Diego, CA, pp 5—8.
11.
Huff J., Cirvello J., Haseman J., Bucher J. (1991). Chemicals associated with site specific neoplasi a in 1394 long-term carcinogenesi s experiments in laboratory rodents. Environ Health Perspect93: 241— 290.
12.
Dybing E., Sanner T. (1999). Species differences in chemical carcinogenesis of the thyroid gland, kidney and urinary bladder. In: Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis, Capen CC, Dybing E, Rice JM, Wilbourne JD (eds). IARC Scientific Publications, No 147, International Agency for Research on Cancer, Lyon, France, pp 15—32.
13.
Lock EA, Reed CJ ( 1998). Xenobiotic metabolizing enzymes of the kidney. Toxicol Pathol26: 18—25.
14.
Montgomery CA Jr, Seely JC (1990). Kidney. In: Pathology of the Fischer Rat: Reference and Atlas, Boorman GA, Eustis SL , Elwell MR, Montgomery CA Jr, MacKenzie WF (eds). Academic Press, Inc, San Diego, CA, pp 127—153.
15.
Hard GC (1998). Mechanisms of chemically induced renal carcinogenesi s in the laboratory rodent. Toxicol Pathol26(1): 104—112.
16.
Swenberg JA, Lehman-McKeeman LD (1999). α2-urinary globulin-associated nephropathy as a mechanism of renal tubule carcinogenesis in male rats. In: Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis , Capen CC, Dybing E, Rice JM, Wilbourne JD (eds). IARC Scientific Publications, No 147, International Agency for Research on Cancer, Lyon, France, pp 95—118.
17.
Short BG (1993). Cell proliferation and renal carcinogenesis. Environ Health Perspect101(Suppl 5): 115—120.
18.
Hard GC, Whysner J., English JC, Zang E., Williams GM (1997). Relationship of hydroquinone-associate d rat renal tumors with spontaneou s chronic progressive nephropathy. Toxicol Pathol25(2): 132—143.
19.
English JC, Perry LG, Vlaovic M., Moyer C., O'Donoghue JL (1994). Measurement of cell proliferation in the kidney s of Fischer 344 and Sprague-Dawley Rats after gavage administration of hydroquinone . Fundam Appl Toxicol23: 397—406.
20.
Melnick RL, Kohn MC ( 1999). Possible mechanisms of induction of renal tubule cell neoplasms in rats associated with α2u-globulin: Role of protein accumulation versus ligand delivery to the kidney. In: Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis, Capen CC, Dybing E, Rice JM, Wilbourne JD (eds). IARC Scientific Publications, No 147, International Agency for Research on Cancer , Lyon, France, pp 119—137.
21.
Cohen SM, Mastui T., Garland EM, Arnold LL (1997). Effects of diet on urinary bladder carcinogenesi s and cancer prevention. J Nutr127(Suppl 5): 826S—829S.
22.
Momose H., Kakinuma H., Shariff SY, Mitchell GB, Rademaker A., Oyasu R. (1991). Tumor-promoting effect of urinary epidermal growth factor in rat urinary bladder carcinogenesis. Cancer Res51(20): 5487—5490.
23.
Yura Y., Hayashi O., Kelly M., Oyasu R. (1989). Identification of epidermal growth factor as a component of the rat urinary bladder tumor-enhancing urinary fractions. Cancer Res49(6): 1548—1553.
24.
Lau JL, Fowler JE Jr, Ghosh L. (1988). Epidermal growth factor in the normal and neoplastic kidney and bladder. J Urol139(1): 170— 175.
25.
MessingEM,HansonP.,UlrichP.,EturkE.( 1987).Epidermalgrowthfactor— interactions with normal and malignant urothelium: In vivo and in situ studies. J Urol138(5): 1329—1335.
26.
Cohen SM (1999). Calcium phosphate-containin g urinary precipitate in rat urinary bladder carcinogenesis. In: Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis, Capen CC, Dybing E, Rice JM, Wilbourne JD (eds). IARC Scientific Publications, No 147, International Agency for Research on Cancer , Lyon, France, pp 175—189.
27.
Fukushima S., Murai T. (1999). Calculi, precipitates and microcrystalluria associated with irritation and cell proliferation as a mechanism of urinary bladder carcinogenesi s in rats and mice. In: Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis, Capen CC, Dybing E, Rice JM, Wilbourne JD (eds). IARC Scientific Publications, No 147, International Agency for Research on Cancer , Lyon, France, pp 159—174.
28.
DeSesso JM (1995). Anatomical Relationships of Urinary Bladders Compared: Their Potential Role in the Development of Bladder Tumors in Humans and Rats . Food Chem Toxic33: 705—714.
29.
Derelanko MJ (1995). Carcinogenesis. In: CRC Handbook of Toxicology, Derelanko MJ, Hollinger MA (eds). CRC Press, Boca Raton, FL.
30.
Historical Controls for NTP 2000-Diet, <http://ntp-server.niehs.nih.gov/ Main_Pages/ntp_hcrs.html>. Updated on February 25, 2002.
31.
Haseman JK, Hailey JR, Morris RW (1998). Spontaneous Neoplasm Incidences in Fischer 344 Rats and B6C3F1 Mice in Two-Year Carcinogenicity Studies. A National Toxicology Program Update. Toxicol Pathol26: 428— 441.
32.
Huff J. (1999). Chemicals associated with tumours of the kidney, urinary bladder and thyroid gland in laboratory rodents from 2000 U.S. National Toxicology Program/National Cancer Institute bioassays for carcinogenicity . In: Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis, Capen CC, Dybing E, Rice JM, Wilbourne JD (eds). IARC Scientific Publications, No 147, International Agency for Research on Cancer, Lyon, France, pp 211—225.
